FABBRI, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 64.644
EU - Europa 23.243
AS - Asia 22.986
SA - Sud America 2.623
Continente sconosciuto - Info sul continente non disponibili 526
AF - Africa 456
OC - Oceania 117
Totale 114.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.412
GB - Regno Unito 8.249
CN - Cina 6.975
SG - Singapore 6.627
IT - Italia 4.954
HK - Hong Kong 2.842
BR - Brasile 2.019
SE - Svezia 1.881
FI - Finlandia 1.857
DE - Germania 1.631
VN - Vietnam 1.627
UA - Ucraina 1.418
BD - Bangladesh 1.338
TR - Turchia 1.081
RU - Federazione Russa 841
FR - Francia 812
KR - Corea 694
CA - Canada 665
BG - Bulgaria 510
IN - India 402
ID - Indonesia 273
NL - Olanda 219
AR - Argentina 204
IE - Irlanda 182
IQ - Iraq 177
MX - Messico 171
JP - Giappone 148
PK - Pakistan 122
ZA - Sudafrica 110
AU - Australia 106
PL - Polonia 98
CO - Colombia 96
ES - Italia 81
CR - Costa Rica 75
AE - Emirati Arabi Uniti 70
CL - Cile 70
BE - Belgio 68
EC - Ecuador 67
RO - Romania 65
MY - Malesia 58
AT - Austria 57
JM - Giamaica 56
EG - Egitto 54
TH - Thailandia 54
VE - Venezuela 54
IL - Israele 49
MA - Marocco 49
PH - Filippine 48
SA - Arabia Saudita 48
GT - Guatemala 45
UZ - Uzbekistan 45
CH - Svizzera 43
TT - Trinidad e Tobago 42
IR - Iran 41
HN - Honduras 39
NP - Nepal 39
TN - Tunisia 38
PY - Paraguay 37
EU - Europa 36
PT - Portogallo 35
JO - Giordania 31
NG - Nigeria 31
PE - Perù 29
SC - Seychelles 29
TW - Taiwan 29
KE - Kenya 28
UY - Uruguay 27
CZ - Repubblica Ceca 25
AZ - Azerbaigian 23
NI - Nicaragua 23
RS - Serbia 23
SV - El Salvador 23
AL - Albania 22
OM - Oman 22
BY - Bielorussia 20
DZ - Algeria 20
SI - Slovenia 20
DK - Danimarca 19
BO - Bolivia 18
LT - Lituania 18
PR - Porto Rico 18
EE - Estonia 16
ET - Etiopia 16
BH - Bahrain 14
KZ - Kazakistan 14
LB - Libano 14
SY - Repubblica araba siriana 13
AO - Angola 12
DO - Repubblica Dominicana 12
HR - Croazia 12
KG - Kirghizistan 12
SN - Senegal 12
BB - Barbados 11
PA - Panama 11
BS - Bahamas 10
CW - ???statistics.table.value.countryCode.CW??? 9
HU - Ungheria 9
LV - Lettonia 9
GE - Georgia 8
GP - Guadalupe 8
Totale 113.924
Salva come PNG Salva come JPEG
Città #
Ashburn 8.155
Southend 6.009
Fairfield 5.796
Woodbridge 4.244
Singapore 4.202
Santa Clara 3.383
Houston 3.119
Jacksonville 3.102
Hefei 2.808
Hong Kong 2.787
San Jose 2.749
Chandler 2.263
Seattle 2.107
Wilmington 1.994
Dearborn 1.993
Cambridge 1.905
Ann Arbor 1.873
Helsinki 1.353
London 1.311
Council Bluffs 1.299
Beijing 1.089
Nyköping 900
Los Angeles 869
The Dalles 809
Chicago 787
Modena 682
New York 652
Seoul 638
San Diego 607
Milan 598
Princeton 574
Izmir 506
Sofia 499
Ho Chi Minh City 498
Des Moines 496
Eugene 486
Hanoi 404
Buffalo 403
Lauterbourg 397
Columbus 388
Rome 347
Dallas 303
Salt Lake City 303
São Paulo 300
Moscow 223
Phoenix 211
Shanghai 182
Dublin 174
Tampa 161
North Bergen 151
Toronto 149
Boardman 142
Reno 142
Elk Grove Village 129
Frankfurt am Main 127
Atlanta 125
Brooklyn 118
Falls Church 118
Jakarta 118
Redwood City 118
Palermo 116
Naples 115
Tokyo 103
Norwalk 98
Guangzhou 97
Da Nang 88
Kent 85
Miami 85
Miano 84
Nanjing 84
Philadelphia 83
San Francisco 79
Warsaw 79
Charlotte 77
Grafing 77
Montreal 75
Sterling 72
Orem 69
Bari 66
Haiphong 66
Lancaster 65
Baghdad 64
Washington 62
Kunming 61
Amsterdam 59
Verona 59
Boston 58
Chennai 58
Mexico City 58
Newark 58
Bologna 56
Falkenstein 56
Turin 56
Detroit 55
Saint Augustine 55
Las Vegas 53
San José 51
Florence 50
Norfolk 50
Jersey City 49
Totale 81.206
Salva come PNG Salva come JPEG
Nome #
Medicina Interna Sistematica 2.170
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary 799
Asma bronchiale 685
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 532
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 524
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 507
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 475
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States 450
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 433
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 432
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial 420
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 416
Effects of a walking aid in COPD patients receiving oxygen therapy 411
Roflumilast:un nuovo farmaco per il trattamento della BPCO 411
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 406
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial 405
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 402
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 393
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 385
Complex chronic co-morbidities of COPD 384
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 383
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 375
La broncopneumopatia cronica ostruttiva nell'anziano 372
Chronic Lung Disease in HIV Patients 370
Cellular and structural bases of chronic obstructive pulmonary disease 369
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 366
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 356
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 351
Treatment of chronic obstructive pulmonary disease and its comorbidities 346
Update in Chronic Obstructive Pulmonary Disease 2005 345
Inhaled Corticosteroids in COPD: Pros and Cons. 344
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 344
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 343
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 341
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 341
From COPD to chronic systemic inflammatory syndrome? 341
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. 337
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma 336
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 335
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 332
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 331
Update in chronic obstructive pulmonary disease 2006 329
Early diagnosis of subclinical multi drug-resistant tuberculosis 327
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials 327
Prognostic role of clusterin in resected adenocarcinomas of the lung. 325
Breakthroughs in internal and respiratory medicine 325
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 323
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 323
Chronic critical illness: the price of survival 322
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 322
Macrolides in the treatment of asthma and cystic fibrosis 320
Clusterin (CLU) and lung cancer 320
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. 318
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 317
Sarcoidosis: challenging diagnostic aspects of an old disease. 316
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 314
Tiotropium versus salmeterol for the prevention of exacerbations of COPD 314
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma 314
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 314
How to Integrate Multiple Comorbidities in Guideline Development 312
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. 312
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial 311
Insufficienza Respiratoria acuta e cronica (cap.21). 310
Pathophysiology of exacerbations of chronic obstructive pulmonary disease 306
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. 305
Benralizumab: for asthma, not yet for COPD 304
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 304
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 303
Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial 300
Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease 300
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 297
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 296
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma 295
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts. 295
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 294
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies 291
Efficacy of standard Rehabilitation in COPD Outpatients with Co-morbidities. 291
Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate 290
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 290
Blood tests for diagnosis of tuberculosis - Reply 289
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa 289
Chronic disease in the elderly: back to the future of internal medicine. 286
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 286
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma 285
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 285
Corticosteroid inhibition of airway microvascular leakage. 284
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing 283
Asthma in the elderly: what we know and what we have yet to know 283
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 282
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial) 281
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 281
Significant chronic airway abnormalities in never-smoking HIV-infected patients 280
Copd, pulmonary fibrosis and ilas in aging smokers: The paradox of striking different responses to the major risk factors 280
Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. 279
Empoyment of the ELISPOT blood test for the diagnosis of latent tuberculosis infection in dialysis patients awaiting renal transplantation 277
Airway eosinophilia in chronic bronchitis during exacerbations. 275
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 275
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 274
Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. 273
Effects of early inpatient rehabilitation after acute exacerbation of COPD 272
Totale 36.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 437.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 437.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.268 0 0 0 0 216 357 636 409 851 561 1.330 908
2022/20236.892 803 496 362 556 845 1.260 116 733 1.035 118 316 252
2023/20244.221 176 311 297 440 772 440 423 530 148 122 143 419
2024/202514.078 611 264 175 868 2.559 1.611 887 778 1.851 905 1.727 1.842
2025/202629.793 1.693 1.357 3.209 2.727 3.304 2.789 4.155 1.475 2.387 2.222 2.488 1.987
2026/202712.019 1.223 2.063 3.421 4.661 651 0 0 0 0 0 0 0
Totale 114.595